4 nominees · 6 ballot items.
Six proposals: (1) Elect four Class III directors; (2) Approve increased non-employee director equity awards; (3) Ratify EY as independent auditors; (4) Advisory (“Say-on-Pay”) vote to approve named executive officer compensation; (5) Approve changes to CEO Shlomi Ben Haim’s compensation; (6) Approve changes to CTO Yoav Landman’s compensation.
Elect four Class III directors—Yoav Landman, Yossi Sela, Elisa Steele, and Luis Felipe Visoso—to serve three-year terms expiring in 2029.
Amend the Non-Employee Director Compensation Program to increase the annual equity grant for certain board committee chairs and the lead independent director from $200,000 to $250,000 per year.
This proposal seeks shareholder approval to amend the company's non-employee director compensation program to increase the annual RSU award for certain board leadership roles—specifically the chairs of the audit, compensation, and nominating and corporate governance committees and the lead independent director—by $50,000 (from $200,000 to $250,000). Management and the nominating and compensation committees state the change is driven by a February 2026 review concluding that those positions require substantially greater time and attention, and that the increase aligns compensation with market benchmarks and the company’s compensation policy. Because JFrog is incorporated under Israeli law, shareholder approval is required for director compensation changes; the company has therefore submitted the amendment for a binding shareholder vote with special voting protections under the Israeli Companies Law. The board recommends a vote FOR, arguing the increase is modest, within policy limits, and necessary to retain and fairly compensate directors who carry heavier oversight burdens—particularly in light of increased responsibilities such as cybersecurity oversight and AI-era governance. Economically, the change is aimed at reducing attrition among committee chairs and ensuring alignment of incentives, although it will modestly increase non-cash dilution through RSU grants. Potential governance concerns include granting higher automatic equity to board chairs without explicit time-limited performance conditions; the company mitigates this by tying grants to service-based vesting and subjecting the program to shareholder approval. Given the procedural special-majority provisions under Israeli law, the vote will also test whether shareholders view the proposed incremental governance spend as appropriate. For a sophisticated investor, the proposal signals active board review of director workloads and a compensation program intended to align sustained governance commitments with compensation, but it should be weighed against dilution and comparative market practices for committee chairs at similar SaaS companies.
Ratify the re-appointment of Kost, Forer, Gabbay & Kasierer (a member of Ernst & Young Global) as the company’s independent registered public accounting firm for the period ending at the close of the next annual general meeting.
Non-binding, advisory 'say-on-pay' vote to approve the compensation of the company's Named Executive Officers as disclosed in the proxy statement.
This advisory “say-on-pay” proposal asks shareholders to non-bindingly approve the compensation paid to the Named Executive Officers as disclosed in the Compensation Discussion and Analysis and related tables. Management frames this vote as an opportunity for shareholders to express their views on overall executive pay and notes it will conduct the advisory vote every three years; the next such advisory vote is scheduled for 2029. This year’s disclosure and recommendation have been materially influenced by extensive post-2025 shareholder engagement, which led the compensation committee to redesign long-term incentives—shifting from one-year PSUs to five-year RSUs—to address investor concerns about short-termism and binary outcomes. Although the vote is advisory and cannot compel change, the board states it will consider the outcome when shaping future compensation, and the compensation committee has already adopted changes that it believes better align pay with long-term shareholder value. For governance analysts, the key issues are whether the compensation changes materially improve long-term alignment (longer vesting and reduced PSU reliance), whether short-term cash metrics remain appropriately calibrated, and whether the disclosure provides sufficient rigor around target-setting and peer selection. The advisory nature of the vote lowers immediate legal risk, but a significant negative vote would likely trigger renewed shareholder engagement and potential further revisions to incentive design. Overall, the proposal is a standard governance mechanism to solicit shareholder feedback on pay practices, and the board's posture—requesting the vote while describing responsive program changes—signals an intent to be responsive to investor concerns.
Approve the Ben Haim Compensation Changes: grant 179,115 RSUs (determined by dividing $10,000,000 by the 20-day average closing price) vesting quarterly over five years beginning June 1, 2026, and payment of $154,981 in perquisites related to Hart-Scott-Rodino fees and associated tax obligations.
This binding proposal asks shareholders to approve specific amendments to CEO Shlomi Ben Haim’s 2026 compensation: a grant of 179,115 RSUs (expressly sized by dividing $10,000,000 by the 20-day average closing price as of February 6, 2026) vesting in equal quarterly installments over five years beginning June 1, 2026, and payment of $154,981 to cover HSR filing fees and related tax obligations. Management frames the grant as responsive to shareholder engagement: the board approved a reduction in the CEO’s target equity compared to 2025 (approximately a 17% reduction at target) while lengthening the vesting schedule to five years to strengthen long-term alignment and retention. Under Israeli Companies Law, the shareholders’ approval is binding and required because the CEO is also an office holder; failure to approve prevents implementation of these changes. The proposal raises customary governance tradeoffs: it increases potential dilution and concentrates additional equity with the CEO, but the extended vesting period and the stated reduction in target value are intended to mitigate short-termism and better align pay with sustained performance. Sophisticated investors should assess the award in the context of recent company performance (strong 2025 results, cloud revenue acceleration, and high NDR), peer median positioning, the CEO’s existing vested/unvested holdings, and potential change-in-control protections that may accelerate vesting. The board’s public justification emphasizes performance, alignment with compensation policy, and responsiveness to shareholder feedback—factors that will matter in evaluating the reasonableness of the package relative to market practice and long-term shareholder value creation.
Approve the Landman Compensation Changes: increase Mr. Landman’s annual salary by NIS 190,000 to NIS 1,650,000 effective March 1, 2026 (retroactive), and grant 80,601 RSUs (determined by dividing $4,500,000 by the 20-day average closing price) vesting quarterly over five years beginning June 1, 2026.
This binding proposal seeks shareholder approval for a retention-oriented compensation package for CTO Yoav Landman: a retroactive base salary increase of NIS 190,000 (to NIS 1,650,000) effective March 1, 2026, and a grant of 80,601 RSUs sized by reference to a $4.5 million target value at the board-approved 20-day average price, vesting quarterly over five years beginning June 1, 2026. Management portrays the package as consistent with the company’s 2025 Compensation Policy and necessary to retain a key technical founder and leader given his central role in product and platform strategy. Because Mr. Landman is both an executive and director, Israeli Companies Law requires shareholder approval for these terms; the vote is therefore binding. From a governance perspective, the extension to five-year vesting increases alignment with long-term shareholder outcomes and reduces short-term incentive pressure, while the salary increase addresses market-competitive pay for a senior technology executive. Risks include dilution from the equity grant and the retroactive nature of the salary increase; investors should weigh these costs against Landman’s historical contribution to product innovation (co-founder and creator of Artifactory) and the company’s strong 2025 performance metrics. The board recommends the change as a measured retention tool within policy limits, but sophisticated investors will want to consider cumulative executive holdings, potential acceleration triggers, and how this package compares with CTO pay at peer SaaS companies.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.07% | 6,145,025 | $288M |
| 2 | Whale Rock Capital Management LLC | 4.97% | 6,019,793 | $283M |
| 3 | Optimus Prime Fund Management Co., Ltd. | 3.88% | 4,700,931 | $221M |
| 4 | WASATCH ADVISORS LP | 3.43% | 4,156,033 | $195M |
| 5 | BNP Paribas Asset Management Holding S.A. | 2.85% | 3,449,244 | $162M |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.79% | 3,380,955 | $159M |
| 7 | FIRST TRUST ADVISORS LP | 2.78% | 3,362,370 | $158M |
| 8 | JPMORGAN CHASE CO | 2.38% | 2,887,906 | $123M |
| 9 | FMR LLC | 1.80% | 2,184,450 | $103M |
| 10 | TimesSquare Capital Management, LLC | 1.73% | 2,097,587 | $98M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.